Posted Oct. 28, 2013 at 9:16 a.m.

Premium Lock Merck narrows full-year revenue forecast as key drug sales slip

Published: 2013-10-28 09:16:43
Updated: 2013-10-28 09:16:43

Merck  Merck

Merck the second-biggest U.S. drugmaker which operates a huge facility in Durham, narrowed its full-year forecast after sales of its top-seller, diabetes pill Januvia, declined....

Read More
Read More

WRAL TechWire any time: Twitter, Facebook

Copyright 2014 WRAL TechWire. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Best of TechWire Insider

Techwire Inside Partners

OUR INSIDERS

Frank Vinluan
Life science
Vivek Wadhwa
Commentary
Dr. Mike Walden
Tech economy
Scroll